Genetic alterations in the adenoma--carcinoma sequence
- PMID: 1516027
- DOI: 10.1002/1097-0142(19920915)70:4+<1727::aid-cncr2820701613>3.0.co;2-p
Genetic alterations in the adenoma--carcinoma sequence
Abstract
Tumorigenesis is thought to be a multistep process in which genetic alterations accumulate, ultimately producing the neoplastic phenotype. A model was proposed to explain the genetic basis of colorectal neoplasia that included several salient features. First, colorectal tumors appear to occur as a result of the mutational activation of oncogenes coupled with the inactivation of tumor-suppressor genes. Second, mutations in at least four or five genes are required to produce a malignant tumor. Third, although the genetic alterations often occur in a preferred sequence, the total accumulation of changes, rather than their chronologic order of appearance, is responsible for determining the tumor's biologic properties. Several different genetic alterations were identified that occur during colorectal tumorigenesis. Activational mutation of the ras oncogene was found in approximately 50% of colonic carcinomas and in a similar percentage of intermediate-stage and late-stage adenomas. Allelic deletions were discovered of specific portions of chromosomes 5, 17, and 18, which presumably harbor tumor-suppressor genes. The target of allelic loss events on chromosome 17 has been shown to be the p53 gene, which is mutated, not only in colonic cancer, but also in a large percentage of other human solid tumors. The gene dcc recently was identified; this candidate tumor-suppressor gene on chromosome 18 appears to be altered in colorectal carcinomas. The protein encoded by the dcc gene has significant sequence similarity to neural cell adhesion molecules and other related cell-surface glycoproteins. By mediating cell-cell and cell-substrate interactions, this class of molecules may have important functions in mediating cell growth and differentiation. Alterations of the dcc gene may interfere with maintenance of these controls and thus may play a role in the pathogenesis of colorectal neoplasia. Another candidate tumor-suppressor gene also was identified on chromosome 5, mcc (for mutated in colorectal cancers). The mcc genetic alterations include one tumor with somatic rearrangement of one mcc allele and several tumors with somatically acquired point mutations in the coding region. Studies currently are ongoing to (1) identify additional tumor-suppressor gene candidates, (2) increase our understanding of normal tumor-suppressor gene function, and (3) demonstrate the functional tumor-suppressor ability of these genes both in vivo and in vitro.
Similar articles
-
Suppressor gene alterations in the colorectal adenoma-carcinoma sequence.J Cell Biochem Suppl. 1992;16G:137-41. doi: 10.1002/jcb.240501124. J Cell Biochem Suppl. 1992. PMID: 1469893 Review.
-
Molecular biology of colorectal cancer.Curr Probl Cancer. 1997 Sep-Oct;21(5):233-300. doi: 10.1016/s0147-0272(97)80003-7. Curr Probl Cancer. 1997. PMID: 9438104 Review.
-
Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.Oncogene. 1993 Nov;8(11):3063-72. Oncogene. 1993. PMID: 8414507
-
CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.Arch Biochem Biophys. 1994 May 1;310(2):504-7. doi: 10.1006/abbi.1994.1199. Arch Biochem Biophys. 1994. PMID: 7513984
-
Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.Oncogene. 1993 Mar;8(3):671-5. Oncogene. 1993. PMID: 8437850
Cited by
-
Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor.BMC Clin Pathol. 2009 Oct 15;9:8. doi: 10.1186/1472-6890-9-8. BMC Clin Pathol. 2009. PMID: 19832985 Free PMC article.
-
Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia.Am J Pathol. 1997 Jan;150(1):201-8. Am J Pathol. 1997. PMID: 9006336 Free PMC article.
-
Novel targeting approaches and signaling pathways of colorectal cancer: An insight.World J Gastroenterol. 2018 Oct 21;24(39):4428-4435. doi: 10.3748/wjg.v24.i39.4428. World J Gastroenterol. 2018. PMID: 30357011 Free PMC article.
-
Association of Chronic Hepatitis B With Colorectal Cancer and Its Dual Impact on Colorectal Liver Metastasis: A Narrative Review.Cureus. 2024 Dec 20;16(12):e76079. doi: 10.7759/cureus.76079. eCollection 2024 Dec. Cureus. 2024. PMID: 39835087 Free PMC article. Review.
-
Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.J Immunother Emphasis Tumor Immunol. 1993 Oct;14(3):182-90. doi: 10.1097/00002371-199310000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8297900 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous